CIMINO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 21.291
AS - Asia 7.300
EU - Europa 4.660
SA - Sud America 1.711
Continente sconosciuto - Info sul continente non disponibili 261
AF - Africa 210
OC - Oceania 41
Totale 35.474
Nazione #
US - Stati Uniti d'America 20.827
SG - Singapore 2.070
CN - Cina 1.552
HK - Hong Kong 1.391
BR - Brasile 1.300
IT - Italia 1.046
GB - Regno Unito 1.042
VN - Vietnam 868
FI - Finlandia 601
SE - Svezia 492
BD - Bangladesh 376
RU - Federazione Russa 303
DE - Germania 296
CA - Canada 289
KR - Corea 205
FR - Francia 172
BG - Bulgaria 159
IN - India 159
AR - Argentina 137
NL - Olanda 132
UA - Ucraina 124
ID - Indonesia 120
TR - Turchia 113
JP - Giappone 89
EC - Ecuador 69
IQ - Iraq 69
EG - Egitto 61
MX - Messico 58
ES - Italia 50
AT - Austria 49
ZA - Sudafrica 46
CL - Cile 45
CO - Colombia 45
PL - Polonia 42
PE - Perù 39
AU - Australia 31
MY - Malesia 30
AE - Emirati Arabi Uniti 29
IE - Irlanda 28
PK - Pakistan 28
VE - Venezuela 28
MA - Marocco 25
PY - Paraguay 22
UZ - Uzbekistan 22
CZ - Repubblica Ceca 21
JM - Giamaica 20
UY - Uruguay 19
IL - Israele 18
SA - Arabia Saudita 18
TH - Thailandia 18
DZ - Algeria 17
KW - Kuwait 17
BZ - Belize 16
KE - Kenya 16
CR - Costa Rica 15
LT - Lituania 15
NP - Nepal 14
TN - Tunisia 14
GT - Guatemala 13
AL - Albania 12
BE - Belgio 10
PH - Filippine 10
PT - Portogallo 10
TW - Taiwan 10
PR - Porto Rico 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
IR - Iran 8
KZ - Kazakistan 8
RO - Romania 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
DK - Danimarca 7
JO - Giordania 7
SI - Slovenia 7
BO - Bolivia 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
PA - Panama 6
SV - El Salvador 6
CY - Cipro 5
EU - Europa 5
HN - Honduras 5
KG - Kirghizistan 5
OM - Oman 5
ET - Etiopia 4
GE - Georgia 4
MK - Macedonia 4
NO - Norvegia 4
AO - Angola 3
BH - Bahrain 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
NG - Nigeria 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
TG - Togo 3
Totale 35.171
Città #
Stanford 8.856
Santa Clara 1.719
Ashburn 1.471
Hong Kong 1.373
Singapore 1.118
Fairfield 906
Helsinki 558
San Jose 525
Chandler 459
London 458
Houston 452
Woodbridge 443
Council Bluffs 407
Nyköping 386
Southend 364
Seattle 346
Beijing 333
Ho Chi Minh City 322
Wilmington 303
Cambridge 301
The Dalles 253
Los Angeles 241
Ann Arbor 227
New York 214
Hefei 213
Seoul 201
Hanoi 198
Princeton 173
Jacksonville 171
Toronto 154
Sofia 153
Modena 150
San Diego 149
Dearborn 139
Dallas 132
Milan 129
São Paulo 109
Buffalo 106
Moscow 101
Chicago 93
Lauterbourg 67
Shanghai 65
Columbus 64
Capelle aan den IJssel 63
Jakarta 63
Rome 61
North Bergen 55
Nuremberg 52
Orem 50
Redondo Beach 50
Tokyo 50
Cairo 42
Frankfurt am Main 41
Rio de Janeiro 41
Eugene 40
Guangzhou 35
Munich 35
Salt Lake City 35
Haiphong 34
Montreal 34
Bologna 30
Da Nang 30
Brooklyn 27
Izmir 27
Philadelphia 27
Phoenix 27
Warsaw 27
Atlanta 26
Denver 26
Lima 26
Amsterdam 25
Brasília 25
Santiago 25
Vienna 25
Curitiba 24
Dublin 24
Quito 24
Reggio Emilia 24
Baghdad 23
Biên Hòa 23
Belo Horizonte 22
Porto Alegre 22
Melbourne 21
Paris 21
Turin 21
Bengaluru 20
Boardman 20
Guayaquil 19
Charlotte 18
Johannesburg 18
Mexico City 18
Sunnyvale 18
Tashkent 18
Kilburn 17
Kuala Lumpur 17
Kuwait City 17
Miano 17
Belize City 16
Elk Grove Village 16
Palermo 16
Totale 26.270
Nome #
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 3.810
Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies 2.177
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 964
Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome 910
Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy 907
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 847
Visual loss and other cranial ischaemic complications in giant cell arteritis 380
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 339
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 336
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 324
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 304
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 290
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 288
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 286
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 278
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 276
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 276
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 271
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 270
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 270
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 268
Ophthalmic manifestations of cat scratch disease 265
Increased expression of interleukin-22 in patients with giant cell arteritis 261
The causes of uveitis in a referral centre of Northern Italy 256
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 256
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 256
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 256
Adalimumab in the treatment of immune-mediated diseases 255
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 238
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 236
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 235
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 231
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 229
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 229
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 228
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 226
Tuberculous uveitis, a resurgent and underdiagnosed disease 224
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 217
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 216
Interleukin-10 promoter polymorphisms in giant cell arteritis 213
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 213
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 211
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 206
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 205
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 202
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 202
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 202
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 199
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 199
Quasi cieco all'improvviso 198
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 198
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 196
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 195
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 195
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 192
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 188
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 187
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 187
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 182
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 181
Uveitis and other ocular complications following covid-19 vaccination 181
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 173
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 171
Primary inflammatory Choriocapillaropathies 170
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 170
Surgical management of post-uveitic epiretinal membranes 170
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 166
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 166
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 165
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 164
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 159
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 155
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 153
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 153
Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis? 150
Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series 148
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 147
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 145
Eosinophilic giant cell arteritis: A different subset of disease? 145
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 143
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 141
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 141
Role of miR-146a and miR-146b in Giant Cell Arteritis. 140
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 140
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 140
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 139
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 136
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 135
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS AND THEIR CLINICAL RELEVANCE 133
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 131
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 131
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 131
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 130
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 130
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 129
Testo-atlante sulle Uveiti 129
Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1 128
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 127
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6 124
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 123
Totale 28.388
Categoria #
all - tutte 140.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.726 0 0 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/202612.919 556 376 1.082 1.538 904 701 1.297 801 937 876 974 2.877
2026/20277.875 6.856 979 40 0 0 0 0 0 0 0 0 0
Totale 35.474